Valeo Pharma (TSE:VPH) has released an update.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Valeo Pharma Inc. has initiated restructuring proceedings under the Companies’ Creditors Arrangement Act with the aim of exploring strategic alternatives and maximizing returns. The company has received court approval for protection and appointed Ernst & Young Inc. as the Monitor to assist in restructuring. Valeo Pharma has also secured interim financing to maintain operations and is committed to a swift and effective restructuring process.
For further insights into TSE:VPH stock, check out TipRanks’ Stock Analysis page.